Review article: The optimal medical management of acute severe ulcerative colitis

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 5, 2010, Pages 615-627

  Hart, A L ^a   Ng, S C ^b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; STEROID;

ANAPHYLAXIS; CORTICOSTEROID THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEADACHE; HUMAN; HYPERTENSION; INFECTION; KIDNEY FAILURE; LONG TERM CARE; LOW DRUG DOSE; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; REVIEW; SEIZURE; STEROID THERAPY; TREMOR; ULCERATIVE COLITIS; VOMITING;

ADRENAL CORTEX HORMONES; ANTIBODIES, MONOCLONAL; COLITIS, ULCERATIVE; CYCLOSPORINE; GASTROINTESTINAL AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77955133196     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04392.x     Document Type: Review

References (85)

1. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1963 4 : 299 315.
2. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. Br Med J 1954 2 : 375 378.
3. Jodorkovsky D, Young Y, Abreu MT. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci 2010 55 : 415 420.
4. Ananthakrishnan AN, Issa M, Binion DG. Clostridium difficile and inflammatory bowel disease. Med Clin North Am 2010 94 : 135 153.
5. Garcia-Erce JA, Gomollon F, Munoz M. Blood transfusion for the treatment of acute anaemia in inflammatory bowel disease and other digestive diseases. World J Gastroenterol 2009 15 : 4686 4694.
6. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007 13 : 1545 1553.
7. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974 1 : 1067 1070.
8. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955 2 : 1041 1048.
9. Turner D, Walsh CM, Steinhart AH, et al. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 2007 5 : 103 110.
10. Jakobovits SL, Travis SP. Management of acute severe colitis. Br Med Bull 2005 75-76 : 131 144.
11. UK IBD Audit second round. Available at: http://www.rcplondon.ac.uk/ clinical-standards/ceeu/Current-work/IBD/Pages/Overview.aspx. Accessed March 2009.
12. Arnott IDR, Leiper K, Down C, et al. Outcome of acute severe ulcerative colitis: data from the national UK IBD audit. Gut 2009 58 : A33.
13. Arnott ID, Leiper K, Down C, et al. Outcome of acute severe ulcerative colitis: data from the UK National IBD audit. Gastroenterology 2010 138 S106.
14. Kaplan GG, McCarthy EP, Ayanian JZ, et al. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology 2008 134 : 680 687.
15. Ananthakrishnan AN, McGinley EL, Binion DG. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis 2009 15 : 182 189.
16. Nguyen GC, Steinhart AH. Nationwide patterns of hospitalizations to centers with high volume of admissions for inflammatory bowel disease and their impact on mortality. Inflamm Bowel Dis 2008 14 : 1688 1694.
17. Roberts SE, Williams JG, Yeates D, et al. Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies. BMJ 2007 335 : 1033.
18. Nicholls RJ, Clark DN, Kelso L, et al. Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis. Aliment Pharmacol Ther 2010 31 : 1310 1321.
19. Travis SP, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut 1996 38 : 905 910.
20. Lindgren SC, Flood LM, Kilander AF, et al. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 1998 10 : 831 835.
21. Ho GT, Mowat C, Goddard CJ, et al. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther 2004 19 : 1079 1087.
22. Randall J, Singh B, Warren BF, et al. Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications. Br J Surg 2010 97 : 404 409.
23. Ananthakrishnan AN, McGinley EL, Binion DG, et al. Simple score to identify colectomy risk in ulcerative colitis hospitalizations. Inflamm Bowel Dis 2010 GT, Lee HM, Brydon G, et al. Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis. Am J Gastroenterol 2009 104 : 673 678.
24. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994 330 : 1841 1845.
25. Van Assche G, D'Haens G, Noman M, et al. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 2003 125 : 1025 1031.
26. Santos J, Baudet S, Casellas F, et al. Efficacy of intravenous cyclosporine for steroid refractory attacks of ulcerative colitis. J Clin Gastroenterol 1995 20 : 285 289.
27. Rayner CK, McCormack G, Emmanuel AV, et al. Long-term results of low-dose intravenous ciclosporin for acute severe ulcerative colitis. Aliment Pharmacol Ther 2003 18 : 303 308.
28. Stack WA, Long RG, Hawkey CJ. Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis. Aliment Pharmacol Ther 1998 12 : 973 978.
29. Hyde GM, Thillainayagam AV, Jewell DP. Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal? Eur J Gastroenterol Hepatol 1998 10 : 411 413.
30. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol 1999 94 : 1587 1592.
31. Message L, Bourreille A, Laharie D, et al. Efficacy of intravenous cyclosporin in moderately severe ulcerative colitis refractory to steroids. Gastroenterol Clin Biol 2005 29 : 231 235.
32. Campbell S, Travis S, Jewell D. Ciclosporin use in acute ulcerative colitis: a long-term experience. Eur J Gastroenterol Hepatol 2005 17 : 79 84.
33. Sternthal MB, Murphy SJ, George J, et al. Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease. Am J Gastroenterol 2008 103 : 937 943.
34. Actis GC, Ottobrelli A, Pera A, et al. Continuously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids. J Clin Gastroenterol 1993 17 : 10 3.
35. de Groen PC, Aksamit AJ, Rakela J, et al. Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med 1987 317 : 861 866.
36. de Groen PC, Wiesner RH, Krom RA. Cyclosporine A-induced side effects related to a low total serum cholesterol level: an indication for a free cyclosporine A assay? Transplant Proc 1988 20 : 374 376.
37. de Groen PC. Cyclosporine, low-density lipoprotein, and cholesterol. Mayo Clin Proc 1988 63 : 1012 1021.
38. Wijdicks EF, Dahlke LJ, Wiesner RH. Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients. Neurology 1999 52 : 1708 1710.
39. Toruner M, Loftus EV Jr., Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008 134 : 929 936.
40. Rahier JF, Ben-horin S, Chowers Y, et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infection in inflammatory bowel disease. Journal of Crohn's Colitis 2009 3 : 47 91.
41. Bojic D, Radojicic Z, Nedeljkovic-Protic M, et al. Long-term outcome after admission for acute severe ulcerative colitis in Oxford: the 1992-1993 cohort. Inflamm Bowel Dis 2009 15 : 823 828.
42. Arts J, D'Haens G, Zeegers M, et al. Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis. Inflamm Bowel Dis 2004 10 : 73 8.
43. Moskovitz DN, Van AG, Maenhout B, et al. Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis. Clin Gastroenterol Hepatol 2006 4 : 760 765.
44. Stange EF, Travis SPL, Vermeire S, et al. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. Journal of Crohn's Colitis 2008 2 : 1 : 1 23.
45. Cacheux W, Seksik P, Lemann M, et al. Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis. Am J Gastroenterol 2008 103 : 637 642.
46. Rowe FA, Walker JH, Karp LC, et al. Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis. Am J Gastroenterol 2000 95 : 2000 2008.
47. Nicholls S, Stephens S, Braegger CP, et al. Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea. J Clin Pathol 1993 46 : 757 760. (Pubitemid 23242431)
48. Kaser A, Mairinger T, Vogel W, et al. Infliximab in severe steroid-refractory ulcerative colitis: a pilot study. Wien Klin Wochenschr 2001 113 : 930 933.
49. Sands BE, Tremaine WJ, Sandborn WJ, et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis 2001 7 : 83 8.
50. Ochsenkuhn T, Sackmann M, Goke B. Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study. Eur J Gastroenterol Hepatol 2004 16 : 1167 1171.
51. Jarnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005 128 : 1805 1811.
52. Lees CW, Heys D, Ho GT, et al. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis. Aliment Pharmacol Ther 2007 26 : 411 419.
53. Kohn A, Daperno M, Armuzzi A, et al. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther 2007 26 : 747 756.
54. Rahier JF, Yazdanpanah Y, Colombel JF, et al. The European (ECCO) Consensus on infection in IBD: what does it change for the clinician? Gut 2009 58 : 1313 1315.
55. Rahier JF, Yazdanpanah Y, Viget N, et al. Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2010 31 : 5 10.
56. Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol 2006 4 : 621 630.
57. Peyrin-Biroulet L, Deltenre P, de SN, et al. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol 2008 6 : 644 653.
58. Lichtenstein GR, Cohen RD, Feagan BG, et al. Safety of Infliximab and other Crohn's disease therapies: Treat Registry data with 27762 patient-year follow-up. Gastroenterology 2010 138 S475.
59. Mackey AC, Green L, Leptak C, et al. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update. J Pediatr Gastroenterol Nutr 2009 48 : 386 388.
60. Monterubbianesi R, Armuzzi A, Papi C, et al. Infliximab for severe ulcerative colitis: short-term and one year outcome of three dose regimen. An Italian multi-centre open-label study. Gastroenterology 2009 138 S685.
61. Venu M, Naik AS, Ananthakrishnan AN. Early infliximab infusion in hospitalised severe UC patients: one year outcome. Gastroenterology 2009 136 A201.
62. Gustavsson A, Jarnerot G, Hertevig E, et al. Colectomy after rescue therapy in intravenous steroid-resistant acute ulcerative colitis: a 3-year follow-up study of the Swedish/Danish Infliximab/Placebo Trial. Gut 2008 57 : A79.
63. Gustavsson A, Jarnerot G, Hertevig E. A 2-year follow up study of the Swedish-Danish infliximab trial in steroid resistant acute ulcerative colitis. Gastroenterology 2007 132 : 983 984.
64. Jakobovits SL, Jewell DP, Travis SP. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Aliment Pharmacol Ther 2007 25 : 1055 1060.
65. Gisbert JP, Gonzalez-Lama Y, Mate J. Systematic review: infliximab therapy in ulcerative colitis. Aliment Pharmacol Ther 2007 25 : 19 37.
66. Ferrante M, Vermeire S, Katsanos KH, et al. Predictors of early response to infliximab in patients with ulcerative colitis. Inflamm Bowel Dis 2007 13 : 123 128.
67. Zisman TL, Lewis JR, Stein AC, et al. Predictors of avoidance of colectomy with infliximab initiation in severe, IV steroid refractory ulcerative colitis. Gastroenterology 2009 136 A660.
68. Walch A, Sjoberg M, Meshkat M, et al. Outcome of rescue therapy in steroid-resistant ulcerative colitis: a retrospective study comparing cyclosporine and infliximab. Gut 2008 57 : P0801.
69. Moccario F, Oliva L, Orlando A, et al. Infliximab or cyclosporine in severe steroid-refractory ulcerative colitis: short and long term results in two groups of treated patients (a historical comparison). Gut 2009 58 : A324.
70. Manosa M, Lopez San RA, Garcia-Planella E, et al. Infliximab rescue therapy after cyclosporin failure in steroid-refractory ulcerative colitis. Digestion 2009 80 : 30 5.
71. Maser EA, Deconda D, Lichtiger S, et al. Cyclosporine and infliximab as acute salvage therapies for each other, in severe steroid-refractory ulcerative colitis. Gut 2007 132 : S1132.
72. Leblanc S, Allez M, Seksik P, et al. Successive treatment with cyclosporine and infliximab in severe ulcerative colitis. Gastroenterology 2009 136 A88.
73. Estelles J, Fernandez-Blanco I, Mendoza JL, et al. Initial response and long-term outcome of adalimunab for ulcerative colitis previously treated with infliximab. Gut 2009 58 : A69.
74. Peyrin-Biroulet L, Laclotte C, Roblin X, et al. Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study. World J Gastroenterol 2007 13 : 2328 2332. (Pubitemid 46860734)
75. Reinisch W, Sandborn WJ, Hommes DW, et al. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis. Journal of Crohn's Colitis 2010 4 7.
76. Baumgart DC, Wiedenmann B, Dignass AU. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. Aliment Pharmacol Ther 2003 17 : 1273 1281.
77. Targan SR, Salzberg BA, Mayer L. A phase I-II study: multiple doe levels of visilizumab are well tolerated and produce rapid and sustained improvement in ulcerative colitis patients refractory to treatment with intravenous steroids. Gastroenterology 2005 128 : A75.
78. Ferrante M, D'Hoore A, Vermeire S, et al. Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis. Inflamm Bowel Dis 2009 15 : 1062 1070.
79. Yang Z, Wu Q, Wu K, et al. Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis. Aliment Pharmacol Ther 2010 31 : 486 492.
80. Andersson P, Soderholm JD. Surgery in ulcerative colitis: indication and timing. Dig Dis 2009 27 : 335 340.
81. Lichtenstein GR, Cohen R, Yamashita B, et al. Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis. J Clin Gastroenterol 2006 40 : 669 677.
82. Haritunians T, Taylor K, Rotter JI, et al. Genetic predictors of medically refractive ulcerative colitis requiring colectomy. Gastroenterology 2009 136 A131.
83. Bressler B, Law JK, Al Nahdi SN, et al. The use of infliximab for treatment of hospitalized patients with acute severe ulcerative colitis. Can J Gastroenterol 2008 22 : 937 940.
84. D'Haens G, Lemmens L, Geboes K, et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 2001 120 : 1323 1329.
85. Holme Ö, Thiis-Evensen E, Vatn MH. Treatment of fulminant ulcerative colitis with cyclosporine A. Scand Journal of Gastro 2009 44 : 1310 1314.